TABLE 1.
Genotype | Tumor overgrowth | Metastasis ratio | p valuea |
---|---|---|---|
WT | − | 0% (n > 200) | NAb |
RasV12 | + | 0% (n > 200) | NAb |
RasV12/dor8 | +++ | 100% (n = 38) | 0c |
RasV12/MetC107 | +++ | 100% (n = 22) | 0c |
RasV12/MetD185 | +++ | 100% (n = 29) | 0c |
RasV12/dor8 + UAS-dor | + | 0% (n = 50) | 1c |
RasV12 + carRNAi | ++ | 29.8% (n = 57) | 0.000001c |
RasV12 + vps16ARNAi | ++ | 34.9% (n = 43) | 0.000006c |
RasV12 + 10% phosphate-buffered saline | + | 0% (n = 44) | NAb |
RasV12 + chloroquine | ++ | 16.1% (n = 56) | 0.0014d |
RasV12 + ethanol | + | 0% (n = 60) | NAb |
RasV12 + monensin | ++ | 11.8% (n = 51) | 0.013e |
a p value was calculated using Fisher's exact test.
b NA, not applicable.
c Compared against RasV12.
d Compared against RasV12 + 10% phosphate-buffered saline.
e Compared against RasV12 + monensin. p < 0.05 is considered as a significant difference.